| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.71e-12 | 37 | 91 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.94e-12 | 38 | 91 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.38e-08 | 21 | 91 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAMTS7 ERVK-8 ADAMTS16 ERVK-19 HTRA3 ERVK-7 ADAMTS13 ERVK-21 ERVK-9 ERVK-10 PLG ERVK-24 | 7.47e-08 | 430 | 91 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.30e-07 | 11 | 91 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.90e-07 | 14 | 91 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAMTS7 SENP3 ERVK-8 ADAMTS16 ERVK-19 HTRA3 ERVK-7 ADAMTS13 ERVK-21 ERVK-9 ERVK-10 PLG ERVK-24 | 1.48e-06 | 654 | 91 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 MYOM1 ERVK-8 ERVK-19 LTBP2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 ZP4 LTBP4 SSPOP EMILIN1 NUP160 OTOG | 2.43e-06 | 891 | 91 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.38e-05 | 37 | 91 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.65e-05 | 38 | 91 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.69e-05 | 46 | 91 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.90e-05 | 152 | 91 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | integrin binding | 1.50e-04 | 175 | 91 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.52e-04 | 23 | 91 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TRAF1 GATA1 ERVK-8 ERVK-19 SMPD1 ERVK-7 ADAMTS13 ERVK-21 ERVK-9 ERVK-10 ERVK-24 AR | 1.94e-04 | 891 | 91 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 2.04e-04 | 5 | 91 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | microfibril binding | 3.04e-04 | 6 | 91 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 3.07e-04 | 29 | 91 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 4.25e-04 | 7 | 91 | 2 | GO:0001517 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 4.67e-04 | 79 | 91 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 7.24e-04 | 9 | 91 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.70e-03 | 188 | 91 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.80e-03 | 14 | 91 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 TRAF1 GATA1 ERVK-8 ERVK-19 SMPD1 ERVK-7 ADAMTS13 ERVK-21 ERVK-9 ERVK-10 ERVK-24 AR | 2.79e-03 | 1189 | 91 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.48e-03 | 136 | 91 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.48e-03 | 136 | 91 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 CTU2 DGKK ERVK-8 NRG2 IRAK1 ERVK-7 ERVK-10 LMTK3 LTBP4 CTU1 | 3.54e-03 | 938 | 91 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.70e-03 | 74 | 91 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 6.22e-03 | 26 | 91 | 2 | GO:0050431 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.15e-07 | 13 | 88 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-8 ERVK-19 SMPD1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 CR1 CR2 ZFP36 | 6.37e-07 | 464 | 88 | 12 | GO:0016032 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.69e-06 | 85 | 88 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.69e-06 | 85 | 88 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.87e-06 | 48 | 88 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.22e-06 | 89 | 88 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 4.14e-06 | 8 | 88 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 8.81e-06 | 10 | 88 | 3 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.61e-05 | 12 | 88 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 2.64e-05 | 14 | 88 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 4.04e-05 | 16 | 88 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 4.04e-05 | 16 | 88 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ERVK-6 ZNF219 MYOM1 SLC34A1 GATA1 ERVK-8 ERVK-19 CACNA1H SEMA6A IRX6 ERVK-21 ERVK-9 PLG EMILIN1 AR SIRT1 NOTCH4 CCN3 | 4.55e-05 | 1483 | 88 | 18 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 6.92e-05 | 19 | 88 | 3 | GO:0002921 | |
| GeneOntologyBiologicalProcess | protein urmylation | 1.07e-04 | 4 | 88 | 2 | GO:0032447 | |
| GeneOntologyBiologicalProcess | tRNA wobble position uridine thiolation | 1.07e-04 | 4 | 88 | 2 | GO:0002143 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 1.09e-04 | 22 | 88 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | response to wounding | GLI1 DGKK GATA1 SMPD1 ADAMTS13 PLG EMILIN1 ZFP36 SVEP1 NOTCH4 FOSL1 | 1.12e-04 | 659 | 88 | 11 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 1.26e-04 | 60 | 88 | 4 | GO:0002920 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.77e-04 | 368 | 88 | 8 | GO:0006310 | |
| GeneOntologyBiologicalProcess | tRNA thio-modification | 1.78e-04 | 5 | 88 | 2 | GO:0034227 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.82e-04 | 66 | 88 | 4 | GO:0002823 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 2.04e-04 | 27 | 88 | 3 | GO:0030449 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 2.42e-04 | 71 | 88 | 4 | GO:0002820 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 RNF169 AP5Z1 SENP3 ERVK-8 ERVK-7 ERVK-10 RNF126 SIRT1 MPG | 4.35e-04 | 648 | 88 | 10 | GO:0006281 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 4.40e-04 | 83 | 88 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | KCP NRG2 HTRA3 SEMA6A LTBP2 NRROS CBL LTBP4 RNF126 EMILIN1 AR SVEP1 SIRT1 CCN3 | 4.74e-04 | 1186 | 88 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | platelet activation | 5.81e-04 | 158 | 88 | 5 | GO:0030168 | |
| GeneOntologyCellularComponent | extracellular matrix | CCN5 ADAMTSL5 ADAMTS7 ADAMTS16 LTBP2 ADAMTS13 PLG ZP4 LTBP4 SSPOP EMILIN1 SVEP1 CCN3 OTOG | 7.83e-07 | 656 | 90 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CCN5 ADAMTSL5 ADAMTS7 ADAMTS16 LTBP2 ADAMTS13 PLG ZP4 LTBP4 SSPOP EMILIN1 SVEP1 CCN3 OTOG | 8.12e-07 | 658 | 90 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | AP-5 adaptor complex | 1.09e-04 | 4 | 90 | 2 | GO:0044599 | |
| GeneOntologyCellularComponent | cell surface | SEMA6C CCN5 RC3H2 ADAMTS7 SLC34A1 IRAK1 TNFRSF13B ADAMTS13 STRC PLG NRROS CR1 CR2 NOTCH4 | 2.72e-04 | 1111 | 90 | 14 | GO:0009986 |
| MousePheno | autoimmune response | 5.99e-05 | 398 | 62 | 9 | MP:0001844 | |
| MousePheno | abnormal self tolerance | 6.23e-05 | 400 | 62 | 9 | MP:0005005 | |
| MousePheno | abnormal immune tolerance | 6.72e-05 | 404 | 62 | 9 | MP:0005000 | |
| MousePheno | abnormal adult Leydig cell differentiation | 1.15e-04 | 4 | 62 | 2 | MP:0013604 | |
| MousePheno | proctitis | 1.15e-04 | 4 | 62 | 2 | MP:0003305 | |
| Domain | TSP_1 | 9.23e-09 | 63 | 80 | 7 | PF00090 | |
| Domain | TSP1 | 1.15e-08 | 65 | 80 | 7 | SM00209 | |
| Domain | TSP1_rpt | 1.15e-08 | 65 | 80 | 7 | IPR000884 | |
| Domain | TSP1 | 1.15e-08 | 65 | 80 | 7 | PS50092 | |
| Domain | VWF_dom | 9.54e-07 | 42 | 80 | 5 | IPR001007 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.11e-06 | 24 | 80 | 4 | IPR013273 | |
| Domain | Growth_fac_rcpt_ | 4.72e-06 | 156 | 80 | 7 | IPR009030 | |
| Domain | EGF_3 | 7.41e-06 | 235 | 80 | 8 | PS50026 | |
| Domain | VWFC_1 | 1.66e-05 | 36 | 80 | 4 | PS01208 | |
| Domain | VWC | 2.06e-05 | 38 | 80 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.06e-05 | 38 | 80 | 4 | PS50184 | |
| Domain | Unchr_dom_Cys-rich | 2.10e-05 | 13 | 80 | 3 | IPR014853 | |
| Domain | C8 | 2.10e-05 | 13 | 80 | 3 | SM00832 | |
| Domain | TIL_dom | 2.66e-05 | 14 | 80 | 3 | IPR002919 | |
| Domain | VWD | 4.07e-05 | 16 | 80 | 3 | SM00216 | |
| Domain | VWF_type-D | 4.07e-05 | 16 | 80 | 3 | IPR001846 | |
| Domain | VWFD | 4.07e-05 | 16 | 80 | 3 | PS51233 | |
| Domain | VWD | 4.07e-05 | 16 | 80 | 3 | PF00094 | |
| Domain | IB | 5.90e-05 | 18 | 80 | 3 | SM00121 | |
| Domain | VWC_out | 6.98e-05 | 19 | 80 | 3 | SM00215 | |
| Domain | Sushi | 7.23e-05 | 52 | 80 | 4 | PF00084 | |
| Domain | IGFBP-like | 8.19e-05 | 20 | 80 | 3 | IPR000867 | |
| Domain | IGFBP | 8.19e-05 | 20 | 80 | 3 | PF00219 | |
| Domain | Semaphorin | 8.19e-05 | 20 | 80 | 3 | IPR027231 | |
| Domain | IGFBP_N_2 | 8.19e-05 | 20 | 80 | 3 | PS51323 | |
| Domain | CCP | 8.39e-05 | 54 | 80 | 4 | SM00032 | |
| Domain | EGF-like_dom | 9.55e-05 | 249 | 80 | 7 | IPR000742 | |
| Domain | SUSHI | 9.68e-05 | 56 | 80 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.04e-04 | 57 | 80 | 4 | IPR000436 | |
| Domain | EGF_1 | 1.11e-04 | 255 | 80 | 7 | PS00022 | |
| Domain | ADAM_spacer1 | 1.26e-04 | 23 | 80 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.26e-04 | 23 | 80 | 3 | PF05986 | |
| Domain | EGF_2 | 1.41e-04 | 265 | 80 | 7 | PS01186 | |
| Domain | Cys_knot_C | 1.63e-04 | 25 | 80 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.63e-04 | 25 | 80 | 3 | PS01225 | |
| Domain | VWC | 2.29e-04 | 28 | 80 | 3 | PF00093 | |
| Domain | Sema | 3.12e-04 | 31 | 80 | 3 | SM00630 | |
| Domain | Semap_dom | 3.12e-04 | 31 | 80 | 3 | IPR001627 | |
| Domain | Sema | 3.12e-04 | 31 | 80 | 3 | PF01403 | |
| Domain | SEMA | 3.12e-04 | 31 | 80 | 3 | PS51004 | |
| Domain | PSI | 3.43e-04 | 32 | 80 | 3 | PF01437 | |
| Domain | Plexin_repeat | 3.43e-04 | 32 | 80 | 3 | IPR002165 | |
| Domain | TB | 3.75e-04 | 7 | 80 | 2 | PF00683 | |
| Domain | Carbohydrate_sulfotransferase | 3.75e-04 | 7 | 80 | 2 | IPR016469 | |
| Domain | - | 4.99e-04 | 8 | 80 | 2 | 3.90.290.10 | |
| Domain | EGF_CA | 5.08e-04 | 86 | 80 | 4 | PF07645 | |
| Domain | TB | 6.40e-04 | 9 | 80 | 2 | PS51364 | |
| Domain | TB_dom | 6.40e-04 | 9 | 80 | 2 | IPR017878 | |
| Domain | DISINTEGRIN_1 | 6.67e-04 | 40 | 80 | 3 | PS00427 | |
| Domain | Reprolysin | 6.67e-04 | 40 | 80 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 6.67e-04 | 40 | 80 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.67e-04 | 40 | 80 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 6.67e-04 | 40 | 80 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 7.17e-04 | 41 | 80 | 3 | IPR001762 | |
| Domain | DUF4939 | 7.97e-04 | 10 | 80 | 2 | PF16297 | |
| Domain | DUF4939 | 7.97e-04 | 10 | 80 | 2 | IPR032549 | |
| Domain | EGF_Ca-bd_CS | 7.99e-04 | 97 | 80 | 4 | IPR018097 | |
| Domain | Pept_M10_metallopeptidase | 8.25e-04 | 43 | 80 | 3 | IPR001818 | |
| Domain | EGF_CA | 8.63e-04 | 99 | 80 | 4 | PS01187 | |
| Domain | PSI | 8.83e-04 | 44 | 80 | 3 | IPR016201 | |
| Domain | EGF-like_CS | 8.90e-04 | 261 | 80 | 6 | IPR013032 | |
| Domain | ASX_HYDROXYL | 8.96e-04 | 100 | 80 | 4 | PS00010 | |
| Domain | LDOC1-rel | 9.72e-04 | 11 | 80 | 2 | IPR032567 | |
| Domain | Insulin_GF-bd_Cys-rich_CS | 9.72e-04 | 11 | 80 | 2 | IPR017891 | |
| Domain | PSI | 1.01e-03 | 46 | 80 | 3 | SM00423 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.11e-03 | 106 | 80 | 4 | IPR000152 | |
| Domain | TIL | 1.16e-03 | 12 | 80 | 2 | PF01826 | |
| Domain | IGFBP_N_1 | 1.16e-03 | 12 | 80 | 2 | PS00222 | |
| Domain | C8 | 1.16e-03 | 12 | 80 | 2 | PF08742 | |
| Domain | CUB | 1.52e-03 | 53 | 80 | 3 | PS01180 | |
| Domain | EGF_CA | 1.87e-03 | 122 | 80 | 4 | SM00179 | |
| Domain | CUB_dom | 1.87e-03 | 57 | 80 | 3 | IPR000859 | |
| Domain | EGF-like_Ca-bd_dom | 1.98e-03 | 124 | 80 | 4 | IPR001881 | |
| Domain | EGF | 2.10e-03 | 126 | 80 | 4 | PF00008 | |
| Domain | EMI | 2.36e-03 | 17 | 80 | 2 | PS51041 | |
| Domain | CTCK_1 | 2.65e-03 | 18 | 80 | 2 | PS01185 | |
| Domain | PLAC | 2.96e-03 | 19 | 80 | 2 | PS50900 | |
| Domain | PLAC | 2.96e-03 | 19 | 80 | 2 | IPR010909 | |
| Domain | EGF | 3.38e-03 | 235 | 80 | 5 | SM00181 | |
| Domain | CT | 3.96e-03 | 22 | 80 | 2 | SM00041 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.00e-07 | 68 | 62 | 6 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.17e-07 | 39 | 62 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.17e-07 | 39 | 62 | 5 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.78e-05 | 143 | 62 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.15e-04 | 109 | 62 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.25e-04 | 111 | 62 | 5 | M27416 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.67e-04 | 32 | 62 | 3 | MM14854 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.22e-11 | 4 | 95 | 4 | 10469592 | |
| Pubmed | 1.07e-10 | 12 | 95 | 5 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.11e-10 | 94 | 95 | 8 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.61e-10 | 5 | 95 | 4 | 12629516 | |
| Pubmed | 1.55e-09 | 75 | 95 | 7 | 20637190 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 7983737 | ||
| Pubmed | 1.55e-07 | 18 | 95 | 4 | 18664271 | ||
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 15063128 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.25e-07 | 248 | 95 | 8 | 24006456 | |
| Pubmed | 1.77e-06 | 73 | 95 | 5 | 22094256 | ||
| Pubmed | 2.34e-06 | 10 | 95 | 3 | 12970426 | ||
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 4.27e-06 | 12 | 95 | 3 | 24179230 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 14635039 | ||
| Pubmed | Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. | 7.38e-06 | 2 | 95 | 2 | 19525969 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26975631 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37591894 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11981823 | ||
| Pubmed | Hormonal control of androgen receptor function through SIRT1. | 7.38e-06 | 2 | 95 | 2 | 16923962 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 1708808 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28252045 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 32302524 | ||
| Pubmed | Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen). | 7.38e-06 | 2 | 95 | 2 | 22685231 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 7.38e-06 | 2 | 95 | 2 | 9460924 | |
| Pubmed | Comparative functional evolution of human and mouse CR1 and CR2. | 7.38e-06 | 2 | 95 | 2 | 18713965 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37833411 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26189291 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23440418 | ||
| Pubmed | CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor. | 7.38e-06 | 2 | 95 | 2 | 23318417 | |
| Pubmed | 1.08e-05 | 16 | 95 | 3 | 22632726 | ||
| Pubmed | 1.85e-05 | 19 | 95 | 3 | 15051154 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 27815387 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9971820 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24449821 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 27471094 | ||
| Pubmed | BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. | 2.21e-05 | 3 | 95 | 2 | 26902145 | |
| Pubmed | Interferon-gamma prevents death of bystander neurons during CD8 T cell responses in the brain. | 2.21e-05 | 3 | 95 | 2 | 19359516 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 29305863 | ||
| Pubmed | Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. | 2.21e-05 | 3 | 95 | 2 | 7690834 | |
| Pubmed | Sema6B, Sema6C, and Sema6D expression and function during mammalian retinal development. | 2.21e-05 | 3 | 95 | 2 | 23646199 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31929563 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 3782802 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20147518 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 10516026 | ||
| Pubmed | Interleukin-1 receptor-associated kinase gene Il1rak maps to the mouse X chromosome. | 2.21e-05 | 3 | 95 | 2 | 9530638 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 17505061 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 2528587 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 7528766 | ||
| Pubmed | Cis interaction between Semaphorin6A and Plexin-A4 modulates the repulsive response to Sema6A. | 2.21e-05 | 3 | 95 | 2 | 20606624 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 2139460 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21172305 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 35931247 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15611103 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 27760825 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 20394732 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16127466 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 4.41e-05 | 4 | 95 | 2 | 28088271 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15632193 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 20010302 | ||
| Pubmed | Stromal androgen and hedgehog signaling regulates stem cell niches in pubertal prostate development. | 4.41e-05 | 4 | 95 | 2 | 34427305 | |
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 4.41e-05 | 4 | 95 | 2 | 11104663 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17242169 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 22022230 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 10673339 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 30217731 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 6.85e-05 | 29 | 95 | 3 | 12435358 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 7.34e-05 | 5 | 95 | 2 | 11401426 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 20613862 | ||
| Pubmed | Complement-dependent P-selectin expression and injury following ischemic stroke. | 7.34e-05 | 5 | 95 | 2 | 17082645 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 36323713 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 20962256 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 19017811 | ||
| Pubmed | 8.95e-05 | 383 | 95 | 7 | 19453261 | ||
| Pubmed | 9.83e-05 | 167 | 95 | 5 | 22159717 | ||
| Pubmed | Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers. | 1.10e-04 | 6 | 95 | 2 | 20484647 | |
| Pubmed | Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). | 1.10e-04 | 6 | 95 | 2 | 26498181 | |
| Pubmed | 1.21e-04 | 35 | 95 | 3 | 28172500 | ||
| Pubmed | 1.22e-04 | 175 | 95 | 5 | 28071719 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 17283066 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 10930463 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 18212046 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 11867212 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 11181564 | ||
| Pubmed | 2.05e-04 | 8 | 95 | 2 | 16289966 | ||
| Pubmed | 2.05e-04 | 8 | 95 | 2 | 1981053 | ||
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 2.05e-04 | 8 | 95 | 2 | 2564419 | |
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 9208847 | ||
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 15814794 | ||
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 23418353 | ||
| Pubmed | 2.93e-04 | 47 | 95 | 3 | 35462405 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 26627825 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 20503258 | ||
| Pubmed | Caspase-7 activates ASM to repair gasdermin and perforin pores. | 3.28e-04 | 10 | 95 | 2 | 35705808 | |
| Pubmed | Sulfation of the human immunodeficiency virus envelope glycoprotein. | 3.28e-04 | 10 | 95 | 2 | 1433500 | |
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 20676093 | ||
| Pubmed | UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination. | 3.28e-04 | 10 | 95 | 2 | 23381138 | |
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 11167130 | ||
| Pubmed | 3.96e-04 | 52 | 95 | 3 | 26633812 | ||
| Pubmed | A family of neofunctionalized Ty3/gypsy retrotransposon genes in mammalian genomes. | 4.00e-04 | 11 | 95 | 2 | 16093683 | |
| Pubmed | 4.00e-04 | 11 | 95 | 2 | 31776257 | ||
| Interaction | GRAP2 interactions | 7.16e-06 | 104 | 90 | 6 | int:GRAP2 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.24e-05 | 19 | 60 | 3 | 50 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.80e-05 | 57 | 60 | 4 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.80e-05 | 20 | 60 | 3 | 736 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 6.47e-05 | 4 | 60 | 2 | 628 | |
| GeneFamily | CYR61/CTGF/NOV matricellular proteins | 1.61e-04 | 6 | 60 | 2 | 1046 | |
| GeneFamily | Ring finger proteins | 2.17e-03 | 275 | 60 | 5 | 58 | |
| GeneFamily | Complement system|Sushi domain containing | 6.35e-03 | 36 | 60 | 2 | 492 | |
| GeneFamily | Sulfotransferases, membrane bound | 6.69e-03 | 37 | 60 | 2 | 763 | |
| Coexpression | NABA_MATRISOME | SEMA6C SEMA6B CCN5 ADAMTSL5 ADAMTS7 ADAMTS16 KCP NRG2 HTRA3 SEMA6A LTBP2 ADAMTS13 PLG MFRP LTBP4 SSPOP EMILIN1 SVEP1 CCN3 OTOG | 6.85e-11 | 1008 | 86 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | SEMA6C SEMA6B CCN5 ADAMTSL5 ADAMTS7 ADAMTS16 KCP NRG2 HTRA3 SEMA6A LTBP2 ADAMTS13 PLG ZP4 LTBP4 SSPOP EMILIN1 SVEP1 CCN3 OTOG | 9.37e-11 | 1026 | 86 | 20 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.39e-10 | 196 | 86 | 10 | M3008 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.36e-08 | 191 | 86 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 2.41e-08 | 275 | 86 | 10 | M5884 | |
| Coexpression | NABA_CORE_MATRISOME | 2.63e-07 | 270 | 86 | 9 | MM17057 | |
| Coexpression | GSE13522_WT_VS_IFNG_KO_SKIN_UP | 6.35e-06 | 138 | 86 | 6 | M2913 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.69e-05 | 18 | 86 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.69e-05 | 18 | 86 | 3 | M13796 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA6C SEMA6B ADAMTSL5 ADAMTS7 ADAMTS16 NRG2 HTRA3 SEMA6A ADAMTS13 PLG MFRP | 2.94e-05 | 738 | 86 | 11 | MM17058 |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | 5.04e-05 | 517 | 86 | 9 | M7140 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN | 5.18e-05 | 200 | 86 | 6 | M8496 | |
| Coexpression | DURAND_STROMA_S_UP | 5.95e-05 | 300 | 86 | 7 | M2581 | |
| Coexpression | DURAND_STROMA_S_UP | 6.47e-05 | 304 | 86 | 7 | MM1083 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | 1.20e-04 | 452 | 86 | 8 | M18685 | |
| Coexpression | NABA_ECM_REGULATORS | 1.35e-04 | 238 | 86 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.48e-04 | 242 | 86 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA6C SEMA6B ADAMTSL5 ADAMTS7 ADAMTS16 NRG2 HTRA3 SEMA6A ADAMTS13 PLG | 1.75e-04 | 751 | 86 | 10 | M5885 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | 2.11e-04 | 368 | 86 | 7 | M41100 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 2.12e-04 | 491 | 86 | 8 | MM455 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SEMA6C RC3H2 TNRC18 MYOM1 ADAMTS16 HTRA3 LTBP2 CBL LTBP4 EMILIN1 AR CCN3 MPG | 1.42e-05 | 797 | 84 | 13 | gudmap_developingGonad_P2_epididymis_1000 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-08 | 189 | 87 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 195 | 87 | 7 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-07 | 199 | 87 | 7 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-07 | 200 | 87 | 7 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-06 | 173 | 87 | 6 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 178 | 87 | 6 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-06 | 179 | 87 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-06 | 182 | 87 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-06 | 182 | 87 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-06 | 183 | 87 | 6 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-06 | 188 | 87 | 6 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-06 | 192 | 87 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.38e-06 | 196 | 87 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 2.46e-06 | 197 | 87 | 6 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | 7f728ca6d5317890c6fcde3ce6c10c0970d49a05 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 2.53e-06 | 198 | 87 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.53e-06 | 198 | 87 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-06 | 198 | 87 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-06 | 198 | 87 | 6 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.60e-06 | 199 | 87 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 199 | 87 | 6 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 199 | 87 | 6 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 199 | 87 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 199 | 87 | 6 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | proximal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 94250991f78ea56810412d00a4bb645eb975478c | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-06 | 200 | 87 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-06 | 200 | 87 | 6 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-mesenchymal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | b54137a4545690f51e154bb05964eaa650c3ca8e | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | distal-1-mesenchymal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 7623f82bd85a0ff7e2097e9281551208dfc602a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 200 | 87 | 6 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.68e-06 | 200 | 87 | 6 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 200 | 87 | 6 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | proximal-mesenchymal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 29f3a5c85404c6537d6405d599ebae281e0d4d4f | |
| ToppCell | distal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 7a79a2de78325d4f1c4535969106a0a44249028c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 87a5a0c252c08ba10316c21f6a9d5244c4d98c74 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.68e-06 | 200 | 87 | 6 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.68e-06 | 200 | 87 | 6 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | medial-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 6ccf44f10d2cee5f48b8f05bd9a1b94057184d56 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 200 | 87 | 6 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.68e-06 | 200 | 87 | 6 | 5ee1318a74ca28a81bd81c20c611de84c17636b0 | |
| ToppCell | (05)_Ciliated-(2)_48hpi|(05)_Ciliated / shred by cell type and Timepoint | 4.52e-06 | 124 | 87 | 5 | fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-06 | 142 | 87 | 5 | d60d2a5d0876a552bc161fc4e2dfe180f88f03a5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 163 | 87 | 5 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.86e-05 | 166 | 87 | 5 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.97e-05 | 168 | 87 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 168 | 87 | 5 | bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-05 | 169 | 87 | 5 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.47e-05 | 176 | 87 | 5 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 177 | 87 | 5 | 41cbb2c109eaa7be366fc0510cce64abc06837b4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-05 | 177 | 87 | 5 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.67e-05 | 179 | 87 | 5 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 181 | 87 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 181 | 87 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 181 | 87 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 182 | 87 | 5 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 186 | 87 | 5 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 187 | 87 | 5 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 187 | 87 | 5 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-05 | 187 | 87 | 5 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.30e-05 | 187 | 87 | 5 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 188 | 87 | 5 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 188 | 87 | 5 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 189 | 87 | 5 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 189 | 87 | 5 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.47e-05 | 189 | 87 | 5 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-05 | 189 | 87 | 5 | 0fe8901e10c619c93b7788792da1706a32102c6e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-05 | 189 | 87 | 5 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-05 | 191 | 87 | 5 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.65e-05 | 191 | 87 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-05 | 191 | 87 | 5 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-05 | 191 | 87 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.65e-05 | 191 | 87 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| Disease | IMMUNODEFICIENCY, COMMON VARIABLE, 2 | 7.04e-05 | 5 | 79 | 2 | 240500 | |
| Disease | Immunodeficiency, common variable, 2 | 7.04e-05 | 5 | 79 | 2 | cv:C3150354 | |
| Disease | hypertrophic cardiomyopathy | 1.11e-04 | 92 | 79 | 4 | EFO_0000538 | |
| Disease | pulse pressure measurement | FNDC3B RC3H2 TRAF1 TRIOBP LTBP2 NEURL1B SSPOP RNF126 SNX19 NUP160 SVEP1 CCN3 | 3.17e-04 | 1392 | 79 | 12 | EFO_0005763 |
| Disease | Immunoglobulin Deficiency, Late-Onset | 3.83e-04 | 11 | 79 | 2 | C2936665 | |
| Disease | Acquired Hypogammaglobulinemia | 3.83e-04 | 11 | 79 | 2 | C2936664 | |
| Disease | Common variable immunodeficiency | 5.42e-04 | 13 | 79 | 2 | cv:C0009447 | |
| Disease | atopic eczema | 5.88e-04 | 252 | 79 | 5 | EFO_0000274 | |
| Disease | Alopecia, Male Pattern | 7.27e-04 | 15 | 79 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 7.27e-04 | 15 | 79 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 7.27e-04 | 15 | 79 | 2 | C0263477 | |
| Disease | Common Variable Immunodeficiency | 7.27e-04 | 15 | 79 | 2 | C0009447 | |
| Disease | osteoporosis (implicated_via_orthology) | 1.18e-03 | 19 | 79 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | Pseudopelade | 1.18e-03 | 19 | 79 | 2 | C0086873 | |
| Disease | Alopecia | 1.18e-03 | 19 | 79 | 2 | C0002170 | |
| Disease | systemic lupus erythematosus | 1.34e-03 | 799 | 79 | 8 | MONDO_0007915 | |
| Disease | congestive heart failure (is_marker_for) | 1.40e-03 | 82 | 79 | 3 | DOID:6000 (is_marker_for) | |
| Disease | Neoplasm Invasiveness | 1.53e-03 | 184 | 79 | 4 | C0027626 | |
| Disease | systemic scleroderma | 1.56e-03 | 85 | 79 | 3 | EFO_0000717 | |
| Disease | open-angle glaucoma | 1.75e-03 | 191 | 79 | 4 | EFO_0004190 | |
| Disease | eosinophil count | LPO GATA1 KCP CACNA1H LTBP2 NEURL1B NRROS LTBP4 SVEP1 NOTCH4 FOSL1 | 1.99e-03 | 1488 | 79 | 11 | EFO_0004842 |
| Disease | Antiglaucoma preparations and miotics use measurement | 2.21e-03 | 26 | 79 | 2 | EFO_0009944 | |
| Disease | HbA1c measurement | 2.22e-03 | 675 | 79 | 7 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLAELPLCPCRDPRS | 346 | Q8N944 | |
| PTCRIISCGELPIPP | 2651 | Q7Z408 | |
| PPSEPCGTPCRLATL | 581 | P17405 | |
| VTQCRPSAALPRCPP | 681 | O43299 | |
| CAPPEGVPACGRRPA | 266 | P13945 | |
| PEPQEACSLEPCPPR | 1001 | Q76LX8 | |
| PSLELERACAPLPCP | 1101 | Q8TE57 | |
| RPCGTEDCEPVEPPR | 1621 | Q9UKP4 | |
| SEPRTTVPLPREPCG | 751 | Q9HBD1 | |
| RNAALPTCCPRPSPA | 571 | Q8IY67 | |
| PLNCAPCPRRSEPVV | 421 | P78412 | |
| PRCTPLGSVLPPCRS | 526 | Q9BY79 | |
| PCSGGPDRPERPECA | 91 | Q5T4H9 | |
| CPEAAPEFRPSPAPC | 166 | Q5KSL6 | |
| LRCEIPCPLPGTDRD | 11 | Q14695 | |
| PSRRGPLPCPLCSRE | 661 | Q96Q04 | |
| CPDPREPASGQRRCP | 111 | Q96KN9 | |
| DCSRPCPPGRQKSPR | 376 | P14222 | |
| PAPVVRCDPCSPYRT | 126 | P22079 | |
| CSALPPPPLEKGRCS | 6 | O14511 | |
| PCCLRPLPSQGAPSV | 16 | P08151 | |
| PLEAVHVPCLCPGRP | 706 | Q2VPB7 | |
| PPAVRPTPCAPLAEC | 276 | P10275 | |
| PSCPLDPAPLREAGC | 606 | P51617 | |
| CQLPDCPPGAVPFRD | 91 | Q6ZMM2 | |
| APDPCPPCPDTRGRA | 356 | Q6ZMM2 | |
| ATLCCARPEPRSPPL | 596 | Q06495 | |
| DREELCGPREPCVLP | 91 | Q9Y5E2 | |
| RGTLPLPPCEARECV | 191 | P15976 | |
| ATTTGREPPDLCPRC | 571 | P87889 | |
| ATTTGREPPDLCPRC | 571 | Q9YNA8 | |
| ATTTGREPPDLCPRC | 571 | P62683 | |
| ATTTGREPPDLCPRC | 571 | P63145 | |
| ATTTGREPPDLCPRC | 571 | Q7LDI9 | |
| ATTTGREPPDLCPRC | 571 | P63130 | |
| ATTTGREPPDLCPRC | 571 | P62685 | |
| ATTTGREPPDLCPRC | 571 | P63126 | |
| ATTTGREPPDLCPRC | 571 | P62684 | |
| LLREPCPPERTVSPC | 311 | Q711Q0 | |
| LAREPPAAPCPARCD | 16 | P83110 | |
| SPQCLRSPPVTRCPN | 776 | P20023 | |
| GRCPATPPTCAPGVR | 41 | P48745 | |
| NETPICDRIPCGLPP | 156 | P17927 | |
| SVPGVTRPSPRPCCV | 271 | Q6ZN03 | |
| EVLVCTTSPDRPGPP | 561 | Q53EP0 | |
| APAARPPRPGACSRC | 276 | Q7Z7A3 | |
| TRPCPCPPLSREGGA | 126 | H7C350 | |
| LCLSRPCPPSRGRSP | 231 | O76076 | |
| AAQAPCPRERCLGPP | 51 | P29372 | |
| VTLCAPCPPRPASPV | 586 | Q14767 | |
| VPPPCDLGRCENTPG | 636 | Q8N2S1 | |
| RIEISSPCCPRQVPP | 326 | Q5T749 | |
| SFCPPRRLDQCPESP | 381 | Q5T749 | |
| QRRPLPCTPGDCPSR | 561 | P22681 | |
| GRRPPQECCSPELGR | 346 | Q9Y6C2 | |
| CDTRLVRAGAPPSPP | 546 | O95180 | |
| EPPRCPLRSCSLPRS | 46 | O15255 | |
| PCCSSELRPLPPSPI | 201 | Q8N813 | |
| IPLTETRTPPGPCCS | 421 | Q2VPK5 | |
| CRPVPCISLSPGPVL | 196 | P15407 | |
| CPLPAASDRVGPPSC | 441 | Q86YC3 | |
| ALPPCDERRCSPFPL | 21 | O43193 | |
| VDLGCPSPRPESCLR | 2471 | Q6ZRI0 | |
| FLCRPPPRAEPDCIS | 86 | Q5HYW3 | |
| LCPAPGDCQVRPPGE | 96 | Q14D33 | |
| RACSRPPTPEGGRPC | 3496 | A2VEC9 | |
| RTEEPPPPAARLCCL | 81 | Q5TG53 | |
| RRSCPPTPTDCPEAL | 1411 | O14513 | |
| VCICEPQPEGPPSLR | 1041 | Q6ZWJ8 | |
| LDQGPRCPARRPCSP | 71 | Q8IXR5 | |
| PVPVDPGTPCRLCRT | 251 | Q5JXC2 | |
| VPRLPDYICPRCESG | 21 | Q9BV68 | |
| VVPRCPRCPADEPLA | 391 | Q96EB6 | |
| PRPEESGCAGCLEPP | 61 | Q8NCN4 | |
| VCSPCTPPKRLPDGR | 386 | Q8NCN4 | |
| LCDIPRCTTPPPSSG | 256 | P00747 | |
| GATPDCVPVRCATPP | 2881 | Q4LDE5 | |
| PPPEVTATARPCLCS | 11 | Q12769 | |
| QEGPRCELRAGPCPP | 226 | Q99466 | |
| PTRPPCTRDGPSDCV | 156 | Q7RTU9 | |
| CDLPRCPPAPEDPLS | 51 | Q9H2D6 | |
| ATTTGREPPDLCPRC | 571 | P63128 | |
| CSRPVCDPPGPADLV | 161 | O43916 | |
| ICSPPLCPGAPRARA | 201 | Q9NS84 | |
| ELPSRGCLPAPRPES | 56 | A0A1B0GUT2 | |
| ECGQTSRPRPIVPDP | 251 | Q96EG3 | |
| TPQVPSPCCRFDSPR | 176 | Q9H4L4 | |
| PEPRVDSPGRTEPCT | 1226 | O15417 | |
| PEDQVPRPRPGCCAA | 366 | Q9H3T3 | |
| RPSPLPEEPGCRCGE | 96 | Q6ZNH5 | |
| ERAECGTTRPPCLPP | 471 | O43295 | |
| PRITPRCGCVDPLPG | 176 | Q8NCR6 | |
| VPDERVPKPRPGCCA | 356 | Q9H2E6 | |
| DPSPPARLLATRPCC | 11 | A8MQ27 | |
| TRPCCGPGPERRPVL | 21 | A8MQ27 | |
| PGTPLARRDPTPVCC | 236 | P26651 | |
| SPDRPPRCPLVCVLS | 821 | C9JH25 | |
| GCPPTVCQDPKEPRA | 21 | Q13077 | |
| DVPPEGRCASAPARP | 821 | Q9H3T2 | |
| RFIPLATCPPCPEAE | 81 | Q92543 | |
| TRALPPPLARCPCAA | 116 | Q6ZRN7 | |
| DPCSCQPRSRPRQSP | 191 | O14836 | |
| EEPPAPPEFRCQVCG | 266 | Q9P2Y4 | |
| RLPCAPSPISRGDCE | 151 | Q12836 | |
| RAPPSPPCDITCLES | 931 | P52179 |